These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 4357683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G, Coope D, Niederman J, Pagano J.
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY, Hann WD.
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [Abstract] [Full Text] [Related]

  • 6. Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines.
    Robinson JE, Andiman WA, Henderson E, Miller G.
    Primates Med; 1978 May; 10():149-55. PubMed ID: 205852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C, Lavoué MF, Patet J, de-Thé G.
    Biomedicine; 1979 Jun; 30(2):102-8. PubMed ID: 224964
    [Abstract] [Full Text] [Related]

  • 14. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
    Rabin H, Neubauer RH, Hopkins RF, Dzhikidze EK, Shevtsova ZV, Lapin BA.
    Intervirology; 1977 Jun; 8(4):240-9. PubMed ID: 194867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infection of Taiwan monkey T and B cells with Epstein-Barr virus.
    Yeh YS, Chu CT, Shieh SH, Yang CS.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Dec; 10(4):96-104. PubMed ID: 211014
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus.
    Katsuki T, Hinuma Y.
    Int J Cancer; 1975 Feb 15; 15(2):203-10. PubMed ID: 165154
    [Abstract] [Full Text] [Related]

  • 18. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T, Sato H, Ogura H, Glaser R.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [Abstract] [Full Text] [Related]

  • 19. Transformation in the presence of dimethyl sulfoxide facilitates recovery of Epstein-Barr virus.
    Wilson GL.
    Intervirology; 1983 Apr 15; 19(1):56-60. PubMed ID: 6298146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.